Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis…
Drug Manufacturers - Specialty & Generic
US, Ardsley [HQ]
Resulting Ratios
15 Records · Starting from 2009
Loading...